The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
暂无分享，去创建一个
Y. Goldberg | N. Gluck | I. Kedar | S. Lieberman | R. Chen-Shtoyerman | T. Golan | N. Abu-Freha | Merav Ben Yehoyada | I. Laish | G. Rosner | R. Bernstein-Molho | E. Half | E. Vainer | Maria Raitses-Gurevich | G. R. Levi | Lior Katz | M. Schechter | A. Dancour | Zohar Levi | Erez Hasnis | Dor Genzel | Maya Aharoni